Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menhycia in Adults Aged 18 to 55 Years
NCT06131554Phase 3Completed
- Sponsor
- CanSino Biologics Inc.
- Start
- Mar 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minoxidil + finasteride in meningococcal meningitis, sponsored by CanSino Biologics Inc.. Started Mar 2024; status: completed.
02
Drugs
minoxidil + finasteride
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT06131554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06131554.